ISSN: 2376-127X

妊娠と小児の健康に関するジャーナル

オープンアクセス

当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

インデックス付き
  • 索引コペルニクス
  • Google スカラー
  • アカデミックキー
  • レフシーク
  • ハムダード大学
  • エブスコ アリゾナ州
  • OCLC-WorldCat
  • パブロン
  • ジュネーブ医学教育研究財団
  • ユーロパブ
  • ICMJE
このページをシェアする

抽象的な

A National Snapshot of Hospitals Performing a High Volume of Endometriosis Procedures is Provided for Surgical Treatment of Endometriotic Women in France Who Intend to Become Pregnant

Shapit Singh

To give a brief overview of endometriosis surgery in high-activity centres in France Methods: Analysis of prospectively gathered data between November French surgical centres for endometriosis. Up to 40 patients could have laparoscopy for endometriosis at each site. Before and two months after surgery, data were gathered. Result. The study included 361 patients. At the month 2 visit, 27 patients were lost to follow-up. In 33.70% of patients, the endometriosis stage was I–II, and in 66.30%, it was III–IV. The most frequent procedure was uterosacral ligament resection, which was followed by rectal surgery, ovarian treatments for endometrioma, procedures for the ureters and bladder. Patients received anti-adhesion treatment. After surgery, a patient's hospital stay typically lasted days. Problems following surgery in 9.34% of patients were noted. Eight patients developed rectovaginal fistulae, one patient had a pelvic abscess, and one patient's bladder atony necessitated a second surgery after a median interval of 31 days. 95.09% of patients said they were satisfied or extremely satisfied with the operation two months following the procedure. According to our study, surgical management of endometriosis is primarily focused on women who present with severe disease and deep localizations, with a 10% overall risk of major complications and a high patient satisfaction rate.

免責事項: この要約は人工知能ツールを使用して翻訳されており、まだレビューまたは確認されていません。